Author:
Zaharee Alireza,Davami Fatemeh
Reference8 articles.
1. Abdolahiasl, A., Nikfar, S., Kebriaeezadeh, A., Dinarvand, R., & Abdollahi, M. (2011). A model for developing a decision support system to simulate national drug policy indicators. Archives of Medical Science, 5, 744–765.
2. Cheraghali, A. M. (2013). Impacts of international sanctions on Iranian pharmaceutical market. Daru, 21(1), 64.
3. Kebriaeezadeh, A., Koopaei, N. N., Abdollahiasl, A., Nikfar, S., & Mohamadi, N. (2013). Trend analysis of the pharmaceutical market in Iran; 1997–2010 policy implications for developing countries. DARU Journal of Pharmaceutical Sciences, 21, 52.
4. Kebrieezadeh, A., Eslamitabar, S., & Khatibi, M. (2009). Iranian pharmaceutical law and regulations (2nd ed.). Tehran: Razico.
5. Ministry of Health and Medical Education (MHME). (2015). Iranian pharmaceutical statistical datasheet (in Farsi).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献